Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
Identifieur interne : 002745 ( PubMed/Corpus ); précédent : 002744; suivant : 002746Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
Auteurs : Kenju Hara ; Akiko Matsuda ; Yuko Kitsukawa ; Keiko Tanaka ; Masatoyo Nishizawa ; Asako TagawaSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2007.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-Dyskinesia Agents, Botulinum Toxins.
- complications : Myasthenia Gravis.
- drug therapy : Blepharospasm, Myasthenia Gravis.
- etiology : Blepharospasm.
- methods : Electromyography.
- Adult, Female, Humans.
DOI: 10.1002/mds.21558
PubMed: 17486596
Links to Exploration step
pubmed:17486596Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.</title>
<author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name>
</author>
<author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name>
</author>
<author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
</author>
<author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21558</idno>
<idno type="RBID">pubmed:17486596</idno>
<idno type="pmid">17486596</idno>
<idno type="wicri:Area/PubMed/Corpus">002745</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.</title>
<author><name sortKey="Hara, Kenju" sort="Hara, Kenju" uniqKey="Hara K" first="Kenju" last="Hara">Kenju Hara</name>
</author>
<author><name sortKey="Matsuda, Akiko" sort="Matsuda, Akiko" uniqKey="Matsuda A" first="Akiko" last="Matsuda">Akiko Matsuda</name>
</author>
<author><name sortKey="Kitsukawa, Yuko" sort="Kitsukawa, Yuko" uniqKey="Kitsukawa Y" first="Yuko" last="Kitsukawa">Yuko Kitsukawa</name>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
</author>
<author><name sortKey="Tagawa, Asako" sort="Tagawa, Asako" uniqKey="Tagawa A" first="Asako" last="Tagawa">Asako Tagawa</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Blepharospasm (drug therapy)</term>
<term>Blepharospasm (etiology)</term>
<term>Botulinum Toxins (therapeutic use)</term>
<term>Electromyography (methods)</term>
<term>Female</term>
<term>Humans</term>
<term>Myasthenia Gravis (complications)</term>
<term>Myasthenia Gravis (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Myasthenia Gravis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Blepharospasm</term>
<term>Myasthenia Gravis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Blepharospasm</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electromyography</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17486596</PMID>
<DateCreated><Year>2007</Year>
<Month>07</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2008</Year>
<Month>04</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>11</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>22</Volume>
<Issue>9</Issue>
<PubDate><Year>2007</Year>
<Month>Jul</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.</ArticleTitle>
<Pagination><MedlinePgn>1363-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hara</LastName>
<ForeName>Kenju</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Matsuda</LastName>
<ForeName>Akiko</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kitsukawa</LastName>
<ForeName>Yuko</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tanaka</LastName>
<ForeName>Keiko</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nishizawa</LastName>
<ForeName>Masatoyo</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tagawa</LastName>
<ForeName>Asako</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018726">Anti-Dyskinesia Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber>
<NameOfSubstance UI="D001905">Botulinum Toxins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018726">Anti-Dyskinesia Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001764">Blepharospasm</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001905">Botulinum Toxins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004576">Electromyography</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009157">Myasthenia Gravis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21558</ArticleId>
<ArticleId IdType="pubmed">17486596</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002745 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002745 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:17486596 |texte= Botulinum toxin treatment for blepharospasm associated with myasthenia gravis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17486596" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |